teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantais, pasirinktinio imunosupresantais - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
dorzolamide actavis
teva b.v. - dorzolamidas - akių lašai (tirpalas) - 20 mg/ml - dorzolamide
dorzolamide elvim
sia elvim - dorzolamidas - akių lašai (tirpalas) - 20 mg/ml - dorzolamide
midazolam b.braun
b.braun melsungen ag - midazolamas - injekcinis ar infuzinis tirpalas - 1 mg/ml; 5 mg/ml - midazolam
furosemide accord
accord healthcare b.v. - furozemidas - injekcinis ar infuzinis tirpalas - 10 mg/ml - furosemide
furosemide ibe
ibe pharma, uab - furozemidas - injekcinis ar infuzinis tirpalas - 10 mg/ml - furosemide
furosemide norameda
norameda, uab - furozemidas - injekcinis ar infuzinis tirpalas - 10 mg/ml - furosemide
midazolam kalceks
as kalceks - midazolamas - injekcinis ar infuzinis tirpalas - 5 mg/ml - midazolam
midazolam baxter
baxter holding b.v. - midazolamas - injekcinis ar infuzinis tirpalas - 1 mg/ml - midazolam